Edward Ashworth is a Postdoctoral Research Associate at the Sydney School of Health Sciences, University of Sydney. He is affiliated with the Thermal Ergonomics Laboratory and the Heat and Health Research Incubator. His research focuses on human adaptations to extreme environments, including heat, altitude, hyperbaric conditions, and space-related stressors. Key projects include improving sleep quality in hot environments and enhancing physical work capacity for outdoor workers. Edward's research interests span environmental physiology, with a focus on thermal tolerance, radiation injury mitigation, and the physiological effects of extreme conditions. He has contributed to studies involving nitrogen kinetics tracking using PET imaging, hyperbaric oxygen therapy, and robotic surgery applications. Awards: Young Investigator Award (2023), Art of Science Contest 1st Prize (2024), Australia Space Biology Summit 1st Place (2022), and Sporting Blue (Auckland University of Technology). Associations: The Physiological Society and American Physiological Society. His work integrates clinical trials, statistical research design, and translational approaches to address challenges in environmental health, cardiovascular disease, and healthy ageing. Current projects aim to optimize thermal tolerance strategies for military and occupational settings.
Adam de la Zerda is an Associate Professor at Stanford University's Department of Structural Biology (School of Medicine) and Electrical Engineering (by courtesy). He develops advanced optical molecular imaging technologies combining nanoparticle contrast agents and adaptive OCT systems for cancer and ophthalmic disease research. Technion-Israel Institute of Technology (BSc, 2005) Stanford University (PhD, 2011) UC Berkeley (Postdoctoral Fellowship) Research Themes : Virtual biopsy using machine learning-enhanced OCT Gold nanorod-based molecular contrast agents Speckle noise reduction for cellular resolution Needle beam optical coherence tomography angiography His 15 most recent publications demonstrate technical innovations in: Metasurface optics for extended depth-of-field Spectral deconvolution of multiple contrast agents Speckle modulation for improved diagnostic clarity Noninvasive lymphatic system mapping Scientific Honors : Pew-Stewart Scholar for Cancer Research AFOSR Young Investigator NIH Early Independence Award Forbes 30 Under 30 (x2) Chan Zuckerberg BioHub Investigator His lab team has developed clinical prototypes including OcuBell Inc. 's ophthalmic imaging systems and Visby Medical 's diagnostic platforms. Current research spans from in vivo glycoprotein imaging to de novo biosensor development for real-time disease monitoring in awake animal models.
Elliot A. Asare, MD, MS, CMQ, FACS serves as Assistant Professor in the Section of Surgical Oncology within the Division of General Surgery at the University of Utah. He specializes in cutaneous malignancies and sarcomas of the retroperitoneum and soft tissues, practicing clinically at both Huntsman Cancer Institute and Intermountain Healthcare Center in Murray. His educational trajectory includes: Phi Beta Kappa graduate with B.S. in Biology and Chemistry (double major) from Randolph-Macon College M.D. from Howard University College of Medicine (Alpha Omega Alpha inductee) General Surgery residency at Medical College of Wisconsin Affiliated Hospitals M.S. in Health Services and Outcomes Research from Northwestern University Complex General Surgical Oncology fellowship at University of Texas MD Anderson Cancer Center Dr. Asare's research program centers on cancer staging methodology, data quality enhancement, prognostication frameworks, and outcomes research with emphasis on health disparities. His work integrates large-scale database analyses (SEER, National Cancer Data Base) to refine AJCC staging systems while addressing inequities in melanoma and sarcoma care across elderly, minority, and rural populations. Recent investigations explore sentinel lymph node biopsy efficacy in aging patients and viral infection impacts on melanoma mortality. His 2023-2025 publications reveal three dominant themes: (1) AJCC Version 9 implementation across multiple cancer types (anal, appendiceal, neuroendocrine), (2) persistent disparities in skin cancer outcomes linked to demographic and geographic factors, and (3) telehealth applications for expanding surgical oncology access. These studies consistently leverage national datasets to validate staging systems while identifying structural barriers to equitable care. Professional recognition includes: Phi Beta Kappa honor society membership Alpha Omega Alpha Medical Honor Society induction Fellowship in the American College of Surgeons (FACS) Dr. Asare actively contributes to surgical oncology education through The SCORE Portal as item writer for soft tissue neoplasm assessments and via publications on medical education frameworks. His institutional affiliations with Huntsman Cancer Institute and Intermountain Healthcare provide platforms for multidisciplinary sarcoma and melanoma management, where he integrates evidence-based staging protocols with patient-centered surgical approaches as evidenced by consistently high patient satisfaction scores (4.9/5 from 166 reviews).
Markus Hovd is a Senior Lecturer at the Section for Pharmacology and Pharmaceutical Biosciences within the Department of Pharmacy at the University of Oslo's Faculty of Mathematics and Natural Sciences. He also maintains an affiliation with the Neurosurgical Department. His work focuses on pharmacokinetic research with applications in clinical practice and personalized medicine. Philosophiae Doctor (PhD), Department of Pharmacy, University of Oslo, 2024 Master of Pharmacy, Department of Pharmacy, University of Oslo, 2019 Hovd's primary research interest centers on the mechanisms behind pharmacokinetic inter-individual variability and the development of models to aid in personalization of medicine. His research methodology includes population- and physiology-based pharmacokinetic models, in vitro-in vivo extrapolation, and clinical trials. His work spans multiple therapeutic areas including kidney transplantation, obesity-related pharmacokinetics, and cerebrospinal fluid dynamics. Analysis of Hovd's publications reveals a strong focus on pharmacokinetic applications in specialized patient populations, particularly kidney transplant recipients and patients who have undergone bariatric surgery. His research demonstrates expertise in population pharmacokinetic modeling, drug transport mechanisms, and the impact of physiological changes on drug disposition. A significant portion of his work addresses the challenges of drug dosing in complex clinical scenarios where standard pharmacokinetic assumptions may not apply. Hovd serves as a representative for temporary teaching staff on both the Teaching Committee and the Department Board at the Department of Pharmacy. His teaching portfolio includes courses in Pharmaceutical Biochemistry, Pharmacotherapy, Pharmaceutical Microbiology, Research Preparation in Biology, and Applied Pharmacokinetics and Dosing in Clinical Practice. Hovd is actively involved in multiple research groups including Pharmacokinetics, Kidney Transplant Medicine, and the KG Jebsen Center for Cerebrospinal Fluid Research, where he contributes his pharmacokinetic expertise to interdisciplinary neuroscience research.
Rodney J. Taylor is a Professor and Chair of the Department of Otorhinolaryngology-Head & Neck Surgery at the University of Maryland School of Medicine. With clinical expertise in head and neck cancer management, skull base surgery, and endocrine surgery, he has led national-recognized research initiatives since joining the faculty in 2001. As Chief of Otolaryngology at the Baltimore Veteran’s Administration Medical Center, he combines clinical excellence with scientific innovation. Education : MD from Harvard Medical School (1995), MPH from University of Michigan School of Public Health (1999) Training : Residency in Otolaryngology-Head & Neck Surgery at University of Michigan (1995-2001) Dr. Taylor's research focuses on improving head and neck cancer survival through immune-cytotoxicity studies, SCCHN cell line analysis, xenograft models, and clinical trials. His collaborations with Dr. Zalzman's lab explore cancer stem cell immortality mechanisms and regenerative medicine advancements. Current research also investigates NK cell FcγRIIIa polymorphisms for personalized antibody therapy. Scientific achievements include developing the Neck Dissection Impairment Index and recognition as a top otolaryngologist. His lab secures funding from NIH, DOD, and philanthropic sources like the Orokawa Foundation and Weitzman family. Research trends emphasize translational oncology, immunotherapy, and stem cell applications in head and neck diseases. Scientific Awards : Ranked among 'America’s Top Otolaryngologists'
Andrew R. Jamieson is an Assistant Professor in the Lyda Hill Department of Bioinformatics at UT Southwestern Medical Center, where he leads a research team focused on developing advanced AI systems for medical education and clinical performance assessment. He was appointed in 2019 and serves as Principal Investigator of the Jamieson Group. Institution: UT Southwestern Medical Center School: School of Health Professions Department: Lyda Hill Department of Bioinformatics Academic Rank: Assistant Professor Dr. Jamieson earned his B.A. in Physics with honors (2006) and Ph.D. in Medical Physics (2012) from the University of Chicago. His early work in computer-aided diagnosis laid the foundation for his career in AI and machine learning. Education: University of Chicago (B.A., Ph.D.) Prior Experience: GE Healthcare, Big Data Analytics Startup (First Data Scientist) Dr. Jamieson's research lies at the intersection of artificial intelligence, medical education, and bioinformatics. His team leverages multimodal data—including video, audio, and text—from the UTSW Simulation Center to train frontier AI models for automated assessment of medical student performance. His work in computational image analysis spans label-free live-cell imaging, spatial biology, and highly multiplexed immunofluorescence, with applications in cancer biology and diagnostics. He has also made significant contributions to public health through the development of the UTSW COVID-19 forecast model. The most recent publications reflect a strong trend toward AI-driven medical education tools, particularly using large language models and multimodal AI for OSCE assessment. Earlier works focus on deep learning in medical imaging, dimensionality reduction, and computer-aided diagnosis in mammography. The research consistently emphasizes interpretability, automation, and clinical translation. Scientific recognition includes being featured on the cover of Cell Systems (July 2021) for work on melanoma cell analysis. His team's development of the first automatic AI grading system for medical student OSCE notes in 2023 marks a major innovation in educational assessment. Featured on cover of Cell Systems (2021) Developed UTSW COVID-19 forecast model Pioneered AI grading system for OSCE notes (2023) Dr. Jamieson is actively involved in mentoring and graduate education. He serves as Course Director for the Master’s in Health Informatics program and contributes to nanocourses at the Clinical Informatics Center. His team includes multiple advisees and collaborators working on NLP, LLMs, and AI/ML in healthcare. He is expanding his group and seeking researchers in AI, data science, and software development. His leadership in the Bioinformatics Core Facility (2018–2021) and ongoing collaborations with pathologists and radiation oncologists demonstrate strong interdisciplinary grant and project engagement. Course Director: Master’s in Health Informatics Mentor to multiple graduate students and researchers Collaborations: Pathology, Radiation Oncology, Surgery, Clinical Informatics The Jamieson Group is a dynamic, interdisciplinary research team at the forefront of applying cutting-edge AI to medical education and clinical data analysis. The lab focuses on natural language processing, multimodal learning, and computer vision, with strong ties to the UTSW Simulation Center and Clinical Informatics Center. The team develops custom pipelines for spatial biology and imaging data and is actively expanding to meet growing research demands.
David A. Jamadar is a Clinical Professor in the Department of Radiology at the University of Michigan Medical School. His academic and clinical work focuses on diagnostic radiology with emphasis on musculoskeletal imaging, ultrasound applications, and cross-sectional imaging techniques. Research Interests: Dr. Jamadar's work spans multiple subfields in radiology, including: Musculoskeletal imaging and postoperative assessment Ultrasound-guided interventions and diagnostic accuracy CT/MRI evaluation of abdominal and pelvic pathologies Incidental findings interpretation in imaging Academic writing and faculty development initiatives Publications Trends: His recent work emphasizes diagnostic imaging applications in hernia detection, tendon pathologies, and post-reconstructive surgery assessment, with a focus on correlating imaging findings with surgical outcomes. Mentorship: Dr. Jamadar is explicitly listed as being available to mentor.
Andrea L. Cheville, M.D., MSCE is a Professor of Physical Medicine and Rehabilitation at Mayo Clinic in Rochester, Minnesota. She holds primary appointment as Consultant in the Department of Physical Medicine & Rehabilitation and joint appointment as Consultant in the Section of Palliative Care, Department of Internal Medicine. Dr. Cheville serves as Medical Director of the Patient-Centered Outcomes Program in the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery since 2014 and was Chair of the Department of Physical Medicine and Rehabilitation from 2020-2021. She is an elected member of the National Academy of Medicine since 2016. Dr. Cheville's research focuses on innovative approaches to cancer rehabilitation and pain management. Her key areas include: Digitally enabled cancer pain management through the ASCENT clinical trial Enhanced cancer symptom control using electronic patient-reported outcomes Non-pharmacological pain management via the NOHARM trial Home discharge planning for Alzheimer's patients through Project HoPe Smartphone-based technology for wheelchair users to monitor seating pressure Her work emphasizes culturally informed, patient-centered care with a focus on underserved populations. Dr. Cheville's research has led to significant advancements in integrating technology into clinical practice to improve patient outcomes, particularly in pain management and cancer rehabilitation. Her publications span clinical trials, health informatics, rehabilitation medicine, and patient-centered outcomes research, with notable emphasis on health equity and underserved communities. Member, National Academy of Medicine (2016-present) Distinguished Academician Award, Association of Academic Physiatrists (2021) Exceptional Women in Medicine, Castle Connolly (2021) Distinguished Member Award, American Academy of Physical Medicine and Rehabilitation (2020) Merit award, National Health Information Awards (2017) As an educator and mentor, Dr. Cheville has contributed to the training of numerous medical professionals in physical medicine and rehabilitation. Her leadership extends to various national committees and organizations where she helps shape the future of rehabilitation medicine and pain management. She has secured multiple NIH grants including the ASCENT trial, Project HoPe, and the NOHARM pragmatic clinical trial.
Dr. Wael E.A. Saad is a distinguished Professor of Clinical Radiology & Imaging Sciences at the University of Utah, where he serves as Director of Interventional Radiology and Vice Chair of Image Guided Procedures. Previously, he held the position of Operations Head of Vascular & Interventional Radiology at the National Institute of Health (NIH) for four years. His academic journey includes faculty positions at University of Michigan (where he served as VIR Director and Medical Director of non-cardiac hybrid-labs), University of Virginia (where he was promoted from Associate to Full Professor and served as VIR Fellowship Program Director), and University of Rochester (where he was promoted from Assistant to Associate Professor). Dr. Saad's educational background includes: MBBCh from Ain Shams University Faculty of Medicine, Cairo, Egypt Surgery Internship at Ain Shams University Hospitals Vascular Surgery training at MedStar Franklin Square Medical Center Internship at Johns Hopkins University School of Medicine Residency in Diagnostic Radiology at University of Rochester Medical Center Fellowship in Vascular & Interventional Radiology at Mallinckrodt Institute of Radiology, Washington University School of Medicine Dr. Saad is internationally recognized for his expertise in Interventional Radiology, with special focus on Portal Hypertension, Liver Transplantation, and Hepato-Biliary Diseases. He is nationally renowned for management of vascular diseases affecting both arterial and venous systems. His research spans a wide range of interventional procedures including transjugular intrahepatic portosystemic shunt (TIPS) creation, balloon-occluded retrograde transvenous obliteration (BRTO) for gastric varices, and management of vascular complications in transplant recipients. He has made significant contributions to the understanding and treatment of portal hypertension and its complications, with numerous publications exploring innovative approaches to managing gastric varices and portal hypertension-related conditions. Dr. Saad has received recognition as a Fellow of the Society of Interventional Radiology (FSIR) and has held leadership positions including former Chair of the Standards of Practice Committee of the Society of Interventional Radiology. His scholarly work includes numerous quality improvement guidelines for interventional radiology procedures. His commitment to advancing the field extends globally through his cofounding of the Middle East Endovascular Therapy (MEET) Symposium and the Society of African Interventional Radiology and Endovascular-therapy (SAFIRE). Throughout his career, Dr. Saad has been dedicated to medical education and training, having served as Fellowship Program Director and mentoring numerous trainees. His global outreach efforts over the past two decades have focused on the Middle East, North Africa, and Sub-Saharan Africa, significantly contributing to the development of interventional radiology services in these regions. His work has particularly emphasized capacity building and education in underserved areas, helping to establish training programs and clinical services across multiple continents.
Edward G. Grant, MD, serves as a Clinical Professor of Radiology (Part-Time) at the University of Southern California (USC), where he was Chair of the Department of Radiology from 2002 to 2019. Prior to USC, he chaired the Imaging Department at Greater Los Angeles VA Healthcare System and held professorial and vice-chair positions at UCLA. His career spans over three decades in academic radiology with a focus on clinical ultrasound innovation and leadership. Dr. Grant is an internationally recognized authority in ultrasound, having pioneered neonatal cranial sonography early in his career. His research encompasses Doppler ultrasound for vascular disease diagnosis, clinical investigation of ultrasound contrast agents, PACS, and advancements in thyroid and liver imaging. He has authored four books and numerous peer-reviewed articles, establishing himself as a leading figure in diagnostic radiology. Analysis of his 15 most recent publications (2021-2025) reveals a strong emphasis on contrast-enhanced ultrasound applications across multiple organ systems, particularly in thyroid nodule characterization (TI-RADS), liver disease quantification, and renal transplant evaluation. His work also addresses emerging areas like AI integration in ultrasound reporting and environmental impacts on fetal development through the MADRES cohort study. His notable awards include: Pasadena Magazine Top Doctor (2011) Dr. Grant has served as an examiner for the American Board of Radiology for 13 consecutive years and remains an active lecturer at national and international conferences. While the provided text does not detail specific grants or student advising, his extensive publication record and leadership roles indicate significant contributions to radiology education and clinical practice advancement.
Greg Adamson is a Clinical Assistant Professor in the Department of Pediatrics - Cardiology at Stanford University School of Medicine and a member of the Maternal & Child Health Research Institute (MCHRI) . He specializes in Interventional Cardiology and Lymphatic Diseases , with clinical expertise in managing conditions like chylothorax and pulmonary arterial hypertension. Medical Education : St. Louis University School of Medicine (2014) Residency : University of California San Francisco (2017) Fellowship : Stanford University Pediatric Cardiology Fellowship (2020) Board Certifications : Pediatrics (2017) and Pediatric Cardiology (2024) Dr. Adamson's research focuses on pediatric pulmonary hypertension , cardiac catheterization protocols , and postoperative chylothorax management . His work includes developing prediction models for early chylothorax detection and evaluating vasopressin's hemodynamic effects in Fontan circulation patients. He has contributed to clinical practice guidelines for progressive pulmonary hypertension in children. His recent publications emphasize procedural efficiency in outpatient cardiac catheterization, valve repair durability in congenital heart disease, and standardized chylothorax algorithms . He utilizes multicenter collaborative frameworks and retrospective cohort analyses , with methodological approaches including logistic regression , Cox proportional hazards modeling , and consensus-building surveys . Key technical areas include lymphatic interventions , hemodynamic monitoring , and predictive analytics in pediatric cardiology. In clinical operations, he investigates same-day discharge criteria for pulmonary hypertension patients and optimal timing for advanced therapies . His work addresses practice variations in chylothorax treatment through quality improvement initiatives , including multidisciplinary algorithm development and ex vivo simulation testing for clinical implementation.
Dr. Emma C. Koesters is an Assistant Professor of Clinical Surgery at the Keck School of Medicine of the University of Southern California. She specializes in Plastic and Reconstructive Surgery with a focus on breast reconstruction, extremity reconstruction, and lymphatic surgery. As Co-director of Keck Medicine's Lymphedema Program, she offers specialized surgical interventions for lymphedema, a common complication of breast cancer treatment. Dr. Koesters received her medical degree from the Weill Cornell College of Medicine, where she was first exposed to reconstructive surgery. She completed an integrated plastic surgery residency at the Keck School of Medicine of USC and pursued additional fellowship training in supermicrosurgery at the University of Chicago Medical Center to focus on physiologic surgery for lymphedema. Her research interests span multiple areas of reconstructive surgery: Breast Reconstruction: Including DIEP flap surgery, immediate device reconstruction, and sensory restoration through neurotization Lymphedema Surgery: Focusing on immediate lymphatic reconstruction and developing effective resources for patients Abdominal Wall Reconstruction: Investigating outcomes predictors and free flap techniques Microsurgical Considerations: Studying vascular steal phenomenon, effects of preoperative hemoglobin, and timing of radiation therapy Autoimmune Disease Management: Exploring flap-based reconstruction in patients with autoimmune conditions Dr. Koesters' publication record demonstrates a strong focus on practical clinical applications that improve patient outcomes. Her recent work examines the role of GLP-1 agonists in surgical patients, insurance coverage impacts on lymphatic reconstruction, and the development of prognostic tools like the Smile Index for cleft palate severity. She emphasizes a comprehensive approach to women's health and breast cancer reconstruction, using advanced microsurgical techniques to tailor procedures to individual patient needs. Her scientific contributions include: Developing the Smile Index as a prognostic severity scale for unilateral cleft palate Investigating the relationship between preoperative hemoglobin levels and microsurgical outcomes Examining the optimal timing for free flap reconstruction following radiation therapy Advocating for the value of reconstructive surgeons in academic medical centers Dr. Koesters believes in working closely with patients to understand their individual goals and optimize postoperative outcomes. She states: "I believe in a comprehensive approach to women's health and breast cancer reconstruction. I use the latest tools available in microsurgery to tailor surgery to each patient's needs and not only restore, but enhance quality of life. Every patient's journey is unique, and I strive to be a long-term partner and advocate for all my patients."
Prof. Ate van der Zee is a Professor of Gynecologic Oncology and Chairman of the Board of Directors at University Medical Center Groningen (UMCG). He leads the Department of Gynecologic Oncology and is a global authority in vulvar and ovarian cancer research. His work focuses on clinical trials, translational research, and improving patient care through managed clinical networks. He holds leadership roles in multiple national/international organizations, including the Dutch Federation of University Medical Centers and the European Society of Gynaecological Oncology (past president). His research spans prognostic biomarkers, sentinel node procedures, and cancer treatment protocols. Prof. van der Zee has authored >270 peer-reviewed publications and supervised 40 PhD students. He combines administrative leadership with active clinical practice, surgical expertise, and mentoring.
Dr. Cheryl Ewing is an Associate Professor of Surgery at the University of California San Francisco (UCSF) Mount Zion Hospital , specializing in breast cancer surgery and sentinel lymph node dissection . Her research explores quality of life disparities among breast cancer survivors, particularly in minority populations, and strategies to customize treatment based on individual patient profiles. University of Michigan, Ann Arbor, BS 1974, Zoology Wayne State University, MD 1983, Medicine University of Michigan Medical School, Residency 1983-1988, Surgery University of Chicago, Fellowship 1988-1991, Surgical Oncology Her research focuses on post-surgery symptom management , barriers to medical care for minority women , and long-term oncological outcomes . Recent studies, such as those in the I-SPY2 Trial, highlight her work on neoadjuvant therapy , mastectomy margin management , and breast reconstruction techniques . Dr. Ewing's publications emphasize invasive lobular carcinoma outcomes, lymph node evaluation via MRI, and health disparities in treatment. Her recent articles (2025-2020) span topics from obesity in oncology to clinical trial design . Susan G. Komen Local Hero Award American Association of Cancer Research Travel Award Women in Medicine Professional Development Travel Award (1992) Young Surgical Investigator Travel Award - American College of Surgeons (2000) Teaching Award - University of New Mexico Dr. Ewing actively mentors residents and fellows , serves on major surgical societies , and contributes to clinical guidelines through her work with the I-SPY2 Trial and other collaborative efforts.
Dr. Isis W. Gayed is an Adjunct Professor in the Radiology & Imaging Sciences department. She is a board-certified nuclear medicine physician with additional certification in nuclear cardiology. Education: MBBS from Faculty of Medicine, University of Khartoum Fellowship at Baylor College of Medicine Residency at Baylor College of Medicine Internship at Hahnemann University Hospital Graduate Training at Michener Institute School of Applied Health Sciences Post-Graduate Training at Toronto General Hospital Research Interests: Nuclear medicine applications in cancer imaging (PET-CT, SPECT/CT) Cardiovascular imaging in oncology patients Diagnostic accuracy of imaging modalities Lymphatic mapping and sentinel node detection Functional imaging for treatment planning Endocrine and parathyroid imaging Publication Trends: Over 20 peer-reviewed articles in clinical nuclear medicine Focus areas: oncology imaging, cardiovascular nuclear medicine, diagnostic techniques Collaborative research with surgical and oncology departments Methodological improvements in SPECT/CT and PET-CT applications Longitudinal studies on radiation therapy outcomes Technical innovations in parathyroid and breast cancer imaging Professional Background: Board certifications in nuclear medicine and nuclear cardiology Extensive clinical training across North America Primary research focus on hybrid imaging modalities (SPECT/CT, PET/CT) Contributions to cancer imaging guidelines and treatment protocols
